Recently, two novel dipyrroles with m/z values 333 and 315 have been identified in vitro (Abu-Bakar et al., 2011; De Matteis et al., 2006) but their presence in biological samples has yet to be determined. In the present study, we measured urinary excretion of dipyrrolic BOMs, as stress markers in mice treated with sodium arsenite.
INTRODUCTION
Exposure to high levels of inorganic arsenic (iAsIII) is associated with a wide range of human ailments, including liver cancer (Yoshida et al., 2004) . The mode of action of arsenic-induced carcinogenesis is not well established but oxidative stress has been proposed to contribute to the complex nature of arsenic toxicity (Schoen et al., 2004) . Arsenic causes oxidative stress through the generation of reactive oxygen species (ROS) (Kumagai and Sumi, 2007) .
One of the adaptive responses to arsenic-induced oxidative stress is induction of haem oxygenase-1 (HMOX1), a rate-limiting enzyme of bilirubin (BR) biosynthesis (Gong et al., 2002; Maines, 1988) . Bilirubin is a potent scavenger of ROS and its production, particularly in situation where cellular antioxidant capacity is reduced, is suggested to be a part of the cellular defence against oxidative stress (Gozzelino et al., 2010; Stocker et al., 1987) . Oxidation of BR by ROS produces various metabolites ranging from tripyrroles to dipyrroles, including propentdyopent (Abu-Bakar et al., 2011; De Matteis et al., 2006; Kunikata et al., 2000; Yamaguchi et al., 1994) . They are collectively called bilirubin oxidative metabolites (BOMs). Urinary tripyrroles and propentdyopent have been identified and measured in human and rat urine. Their levels were found to be elevated during physiological and psychological stress (Yamaguchi et al., , 2002 Kunikata et al., 2000) .
(Syndey, Australia). Bilirubin and reduced glutathione (GSH) were from Sigma-Aldrich (Sydney, Australia). Goat anti-rabbit IgG and goat anti-mouse IgG conjugated with horseradish peroxidase were obtained from Thermo Fisher Scientific Inc. (Vic, Australia). Monoclonal antimouse Hmox1 antibody and polyclonal anti-rabbit β-actin antibody were obtained from Stressgen Biotech (BC, Canada) and Abcam (Cambridge, UK), respectively.
Animal treatment
Seventy 7-9 week-old DBA/2J male mice (Animal Resources Centre, Western Australia) were divided into seven groups of ten mice per group. They were housed in filter-top polycarbonate cages containing wood chip bedding and maintained in a 12-hr light/12-hr dark cycle with free access to standard mouse chow and tap water. The animals were treated i.p. with single dose of 40 μmol NaAsO 2 /kg bw (in saline). Animals in the control group were given normal saline solution only. Immediately after treatment the animals were transferred to metabolic cages (10 animals/cage). The animals were sacrificed at 1, 3, 6, 18, 24, and 48 hr with an overdose of CO 2 . The livers (minus the gallbladders) of individual animals were excised. Pooled urine samples were kept in the dark and in cool condition during collection and immediately frozen to -80°C once collected at the appropriate time. Samples collections were done every 12 hr. All the experimental procedures were approved by the institutional animal ethics committee (QHFSS AEC 07P07).
Protein analysis and measurement of hepatic glutathione and bilirubin
Liver microsomal and cytosolic fractions were prepared by a modified differential centrifugation method previously described (Abu-Bakar et al., 2005) . Protein concentrations of the microsomal and cytosolic fractions were determined by the Lowry method (Lowry et al., 1951) . HMOX1 protein was determined by Western blotting. Microsomal proteins (5 μg) were separated by NuPAGE 4-12% w/v Bis-Tris 1.0 mm mini-gel (Invitrogen, Sydney, Australia) and blotted onto a PVDF membrane (Bio-Rad Labs, Hercules, CA, USA). Antibodies for HMOX1, and β-actin were used in a 1:250 and 1:5000 dilutions, respectively. All solutions contained 5% non-fat dry milk and the detection was performed with the ECL Plus™ Western Blotting Detection Reagents (GE Healthcare, Pittsburg, PA, USA). Blots were scanned with HP scanjet 5530 (Hewlett Packard, Palto Alto, CA, USA) and the intensity of each band was quantitated using the software NIH ImageJ (1.30), a public domain imageprocessing and analysis program for Windows (http://rsb. info.nih.gov/nih-image/).
Reduced glutathione (GSH) levels were measured using the GSH assay kit (Stressgen Biotech) according DBA/2J mice were treated with a single i.p. dose of 40 μmol NaAsO 2 /kg bw and the livers were excised at 0, 1, 3, 6, 18, 24 and 48 hr after treatment. Data are mean ± S.E. of four determinations. *, p < 0.05 compared with control. to the manufacturer's protocol. Hepatic oxidised glutathione (GSSG) were determined by derivatising glutathione with 2-vinylpyridine. Total and conjugated BR in liver cytosolic fractions were measured using a BR assay kit (BioAssay Systems, Hayward, CA, USA) according to the manufacturer's protocol based on the Jendrassik-Grof method (Mori, 1978) . Total BR is assessed using caffeine benzoate to split BR from the unconjugated BR protein complex.
Analysis of bilirubin oxidative metabolites (BOMs)
Extraction of BOMs from mice urine was performed according to a previously described method with modifications. Briefly, 5-10 ml of urine samples were centrifuged at 2,000 × g for 20 min. The resulting supernatant were lyophilised and diluted with equal amount of 5% acetic acid, which were then separated on an Oasis ® HLB 6cc (Waters, Australia) to give seven fractions, (Fr 1, 0%; Fr 2, 10%; Fr 3, 20%; Fr 4, 30%; Fr 5, 40%; Fr 6, 50%; Fr 7, 100%: acetonitrile/5% acetic acid, v/v). Ten ml of eluting solvents was added in succession to the cartridges. This clean up step has been reported numerously for urine detection of tripyrroles (Yamaguchi et al., 1994 . Each fraction was lyophilised, reconstituted in 200 μl of 1:1 acetonitrile/MQH 2 O, and filtered (0.45 micron filter membrane) prior to assessment by HPLC/MS/MS. Bilirubin and its oxidative metabolites were determined by HPLC-MS/MS (AB/Sciex API4000Q mass spectrometer, AB Sciex, Framingham, MA, USA) equipped with an electrospray (TurboV) interface coupled to a HPLC system (Prominence Model XYZ, Shimadzu Corp., Kyoto, Japan) as describe previously (Abu-Bakar et al., 2011) . For positive control, in vitro oxidation of BR was generated by incubating BR with Fe-EDTA/H 2 O 2 for 1 hr. Bilirubin was not detected in all fractions of treated and control urine samples.
Statistical analysis
Significance was assessed with a t test, and p < 0.05 was considered significant. Fig. 1 shows iAsIII-induced oxidative stress in the liver. Exposure of mice to iAsIII resulted in time-dependent reduction of reduced glutathione (GSH) and elevation of oxidised glutathione (GSSG). Perturbation of GSSGto-GSH ratio is a known traditional marker of oxidative stress and has been shown to activate induction of HMOX1 (Ryter and Choi, 2002) . Indeed, Fig. 2A shows that HMOX1 protein was induced time-dependently by the treatment, with maximal levels reached at 6 hr after treatment. Elevated HMOX1 expression resulted in augmented hepatic BR production (Fig. 2B) . However, the increase in the total BR levels was modest compared to the strong induction of HMOX1. For instance, HMXO1 protein levels in treated groups increased by 200 to 400% ( Fig. 2A) during the course of the study but the hepatic total BR levels increased maximally by only 100% of control (Fig. 2B) . Additionally, the profile of BR levels do not correspond to that of the HMOX1, where the increase was "delayed" reaching its maximum only at 6 hr, after which a rapid decline to control levels took place at 18 hr, despite a relatively high HMOX1 protein levels (Fig. 2) .
RESULTS AND DISCUSSION
The principal metabolic route for elimination of excessive BR is conjugation with glucuronic acid in the liver and elimination in the bile, a reaction catalysed by the hepatic uridine-diphosphate-glucuronosyltransferase 1A1 (UGT1A1) (Tukey and Strassburg, 2000) . It is therefore interesting to note that the amount of conjugated BR (BRC) declined from 61% of the total BR in control animals to ≤ 30% of the total BR in treated animals (Fig. 2B) . By contrast, the proportion of unconjugated BR (BRU) relative to total BR increased from 39% in control mice to 67-72% in treated mice (Fig. 2B ). These observations suggest that a pathway for BR clearance in addition to glucuronidation is activated by arsenicinduced oxidative stress.
We have recently demonstrated that oxidation of BRU by ROS in vitro produced various isomeric dipyrroles with m/z values of 301, 315, and 333 (Abu-Bakar et al., 2011) . The m/z 301 metabolite was purported to be propentdyopent (De Matteis et al., 2006) . To explore the potential of BR oxidation as another pathway of BR clearance induced by arsenite treatment we screened the three dipyrroles in urine of treated and control mice. Based on the retention times and m/z values obtained from chemical oxidation of BR (Fig. 3B) , we found the three predominant metabolites in mice urine (Fig. 3C) . Ion m/z 301 was the main metabolite excreted in the urine of control and treated mice and significantly increased after 6 hr (> 100% of control) by the treatment (Fig. 4A) . Ions m/z 333 and 315 were not detected in the urine of control mice at 6 hr but appeared at 18 hr after treatment, with ion m/z 333 levels gradually increased with time and ion m/z 315 levels remained steady (Figs. 4B and C) . By contrast, ions m/z 333 and 315 were seen in the urine of treated mice as early as 6 hr after treatment and remained steady thereafter (Figs. 4B and C) . Although the amounts of ions m/z 333 and 315 excreted in the urine are smaller than ion m/z 301, their levels in treated groups are significantly higher than in the urine of control mice (> 500% of control). In conclusions, acute arsenite exposure causes oxidative stress, which is associated with temporal induction of hepatic HMOX1, the rate-limiting enzyme of BR biosynthesis, and elevated urinary excretion of BOMs. It is plausible that BOMs can be used as marker for oxidative stress.
